NCT00992446 2020-03-18Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin LymphomaFred Hutchinson Cancer CenterPhase 2 Completed27 enrolled 13 charts